{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:47:55Z","timestamp":1786992475954,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.jhep.2010.10.043","type":"journal-article","created":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T04:14:58Z","timestamp":1292645698000},"page":"359-368","source":"Crossref","is-referenced-by-count":52,"title":["Overexpression of von Hippel\u2013Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice"],"prefix":"10.1016","volume":"55","author":[{"given":"Jizhou","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangha","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey W.","family":"Krissansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.10.043_b0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jhep.2010.10.043_b0010","doi-asserted-by":"crossref","unstructured":"Samuel M, Chow PK, Chan Shih-Yen E, Machin D, Soo KC. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev 2009;21:CD001199.","DOI":"10.1002\/14651858.CD001199.pub2"},{"key":"10.1016\/j.jhep.2010.10.043_b0015","doi-asserted-by":"crossref","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology; 2010. www.aasld.org.","DOI":"10.1002\/hep.24199"},{"key":"10.1016\/j.jhep.2010.10.043_b0020","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2006.08.4046","article-title":"Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin","volume":"25","author":"Gish","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2010.10.043_b0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","article-title":"The von Hippel\u2013Lindau tumour suppressor protein: O2 sensing and cancer","volume":"8","author":"Kaelin","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhep.2010.10.043_b0030","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/cdd.2008.21","article-title":"The role of hypoxia-inducible factors in tumorigenesis","volume":"15","author":"Rankin","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jhep.2010.10.043_b0035","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1017\/S1462399409001173","article-title":"Targeting the hypoxia-inducible factor (HIF) pathway in cancer","volume":"11","author":"Poon","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.jhep.2010.10.043_b0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1096\/fj.02-0445fje","article-title":"Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs","volume":"17","author":"Wiesener","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2010.10.043_b0045","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.3748\/wjg.v13.i23.3176","article-title":"Prognostic significance of HIF-2alpha\/EPAS1 expression in hepatocellular carcinoma","volume":"13","author":"Bangoura","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.10.043_b0050","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1038\/onc.2008.160","article-title":"Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice","volume":"27","author":"Rankin","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2010.10.043_b0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1535-6108(02)00044-2","article-title":"The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma","volume":"1","author":"Maranchie","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2010.10.043_b0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14728220903431069","article-title":"The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy","volume":"14","author":"Lin","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jhep.2010.10.043_b0065","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/jnci\/djn174","article-title":"KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment","volume":"100","author":"Sch\u00f6n","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2010.10.043_b0070","first-page":"437","article-title":"Differential enhancement of the anti-cancer effect of doxorubicin by Akt inhibitors on human breast cancer cells with differing genetic backgrounds","volume":"21","author":"Wang","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jhep.2010.10.043_b0075","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2005.04.014","article-title":"IKK beta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis","volume":"121","author":"Maeda","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2010.10.043_b0080","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1128\/MCB.25.17.7546-7556.2005","article-title":"Mechanism of von Hippel\u2013Lindau protein-mediated suppression of nuclear factor kappa B activity","volume":"25","author":"An","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2010.10.043_b0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2007.09.010","article-title":"PVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kB agonist Card9 by CK2","volume":"28","author":"Yang","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2010.10.043_b0090","first-page":"7076","article-title":"The von Hippel\u2013Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway","volume":"63","author":"Qi","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2010.10.043_b0095","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/sj.onc.1208348","article-title":"VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism","volume":"24","author":"An","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2010.10.043_b0100","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/sj.onc.1206373","article-title":"Loss of von Hippel\u2013Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor","volume":"22","author":"Baba","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2010.10.043_b0105","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1128\/MCB.19.9.5902","article-title":"The von Hippel\u2013Lindau tumor suppressor gene inhibits hepatocyte growth factor\/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells","volume":"19","author":"Koochekpour","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2010.10.043_b0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01874","article-title":"Chemokine receptor CXCR4 downregulated by von Hippel\u2013Lindau tumour suppressor pVHL","volume":"425","author":"Staller","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2010.10.043_b0115","doi-asserted-by":"crossref","first-page":"9056","DOI":"10.1158\/0008-5472.CAN-09-1770","article-title":"Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells","volume":"69","author":"Roberts","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2010.10.043_b0120","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/emboj.2008.96","article-title":"PVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation","volume":"27","author":"Frew","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2010.10.043_b0125","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/sj.gt.3302118","article-title":"Regression of solid tumors by engineered overexpression of von Hippel\u2013Lindau tumor suppressor protein and antisense hypoxia-inducible factor-1alpha","volume":"10","author":"Sun","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.jhep.2010.10.043_b0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/sj.cgt.7700907","article-title":"Overexpression of von Hippel\u2013Lindau tumor suppressor protein and antisense HIF-1alpha eradicates gliomas","volume":"13","author":"Sun","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jhep.2010.10.043_b0135","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/j.1349-7006.2008.00905.x","article-title":"Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma","volume":"99","author":"Liu","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jhep.2010.10.043_b0140","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1089\/hum.2006.17.1262","article-title":"Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction","volume":"17","author":"Johnson","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jhep.2010.10.043_b0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2009.10.001","article-title":"Downregulation of nuclear factor-\u03baB P65 subunit by small interfering RNA synergizes with gemcitabine to treat pancreatic cancer","volume":"291","author":"Kong","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhep.2010.10.043_b0150","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.4049\/jimmunol.179.9.6009","article-title":"A crucial role for dendritic cell (DC) IL-10 in inhibiting successful DC-based immunotherapy: superior antitumor immunity against hepatocellular carcinoma evoked by DC devoid of IL-10","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2010.10.043_b0155","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/carcin\/bgm004","article-title":"Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice","volume":"28","author":"Mai","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhep.2010.10.043_b0160","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1442-2042.2008.02025.x","article-title":"Two hour exposure to sodium butyrate sensitizes bladder cancer to anticancer drugs","volume":"15","author":"Wang","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.jhep.2010.10.043_b0165","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/hum.2008.164","article-title":"Downregulating hypoxia-inducible factor 1 augments transcatheter arterial embolization to treat hepatocellular carcinomas in rats","volume":"20","author":"Sun","year":"2009","journal-title":"Human Gene Ther"},{"key":"10.1016\/j.jhep.2010.10.043_b0170","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2010.10.043_b0175","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1038\/onc.2008.300","article-title":"NF-kappaB signaling, liver disease and hepatoprotective agents","volume":"27","author":"Sun","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2010.10.043_b0180","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2008.12.031","article-title":"NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy","volume":"278","author":"Wu","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhep.2010.10.043_b0185","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1097-2765(04)00131-5","article-title":"Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B","volume":"13","author":"Campbell","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2010.10.043_b0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bcp.2003.08.039","article-title":"Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues","volume":"67","author":"Ashikawa","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2010.10.043_b0195","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1006\/bbrc.1998.9839","article-title":"Recombinant adenovirus expressing Von Hippel\u2013Lindau-mediated cell cycle arrest is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1","volume":"253","author":"Kim","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.10.043_b0200","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1158\/0008-5472.CAN-06-0325","article-title":"Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma","volume":"66","author":"Kern","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2010.10.043_b0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1096\/fj.01-0589fje","article-title":"von Hippel\u2013Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis","volume":"16","author":"Jones","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2010.10.043_b0210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bbrc.2004.03.050","article-title":"Regulatory role of vHL\/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells","volume":"317","author":"Wang","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.10.043_b0215","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature06905","article-title":"NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha","volume":"453","author":"Rius","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2010.10.043_b0220","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1073\/pnas.0812801106","article-title":"Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells","volume":"106","author":"Lee","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2010.10.043_b0225","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1158\/0008-5472.CAN-04-3494","article-title":"Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells","volume":"65","author":"Ho","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2010.10.043_b0230","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma, a randomised controlled trial","volume":"359","author":"Llovet","year":"2003","journal-title":"Lancet"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810011773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810011773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:17:45Z","timestamp":1712017065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827810011773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0168827810011773"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.10.043","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}